|
Name |
Penochalasin J
|
| Molecular Formula | C32H38N2O3 | |
| IUPAC Name* |
(1S,7E,9S,11E,13S,16S,17R,18S)-18-(1H-indol-3-ylmethyl)-7,9,15,16-tetramethyl-19-azatricyclo[11.7.0.01,17]icosa-7,11,14-triene-2,5,20-trione
|
|
| SMILES |
C[C@H]\1C/C=C/[C@H]2C=C([C@H]([C@@H]3[C@@]2(C(=O)CCC(=O)C/C(=C1)/C)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)C
|
|
| InChI |
InChI=1S/C32H38N2O3/c1-19-8-7-9-24-16-21(3)22(4)30-28(17-23-18-33-27-11-6-5-10-26(23)27)34-31(37)32(24,30)29(36)13-12-25(35)15-20(2)14-19/h5-7,9-11,14,16,18-19,22,24,28,30,33H,8,12-13,15,17H2,1-4H3,(H,34,37)/b9-7+,20-14+/t19-,22+,24-,28-,30-,32+/m0/s1
|
|
| InChIKey |
MYTCOOYZKCVFJE-ZOHYDBOYSA-N
|
|
| Synonyms |
Penochalasin J
|
|
| CAS | NA | |
| PubChem CID | 139590395 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 498.7 | ALogp: | 4.5 |
| HBD: | 2 | HBA: | 3 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 79.0 | Aromatic Rings: | 5 |
| Heavy Atoms: | 37 | QED Weighted: | 0.396 |
| Caco-2 Permeability: | -4.886 | MDCK Permeability: | 0.00002320 |
| Pgp-inhibitor: | 0.948 | Pgp-substrate: | 0.997 |
| Human Intestinal Absorption (HIA): | 0.09 | 20% Bioavailability (F20%): | 0.872 |
| 30% Bioavailability (F30%): | 0.031 |
| Blood-Brain-Barrier Penetration (BBB): | 0.919 | Plasma Protein Binding (PPB): | 98.16% |
| Volume Distribution (VD): | 1.342 | Fu: | 2.39% |
| CYP1A2-inhibitor: | 0.257 | CYP1A2-substrate: | 0.27 |
| CYP2C19-inhibitor: | 0.956 | CYP2C19-substrate: | 0.55 |
| CYP2C9-inhibitor: | 0.882 | CYP2C9-substrate: | 0.837 |
| CYP2D6-inhibitor: | 0.356 | CYP2D6-substrate: | 0.731 |
| CYP3A4-inhibitor: | 0.967 | CYP3A4-substrate: | 0.271 |
| Clearance (CL): | 9.338 | Half-life (T1/2): | 0.291 |
| hERG Blockers: | 0.164 | Human Hepatotoxicity (H-HT): | 0.128 |
| Drug-inuced Liver Injury (DILI): | 0.294 | AMES Toxicity: | 0.529 |
| Rat Oral Acute Toxicity: | 0.959 | Maximum Recommended Daily Dose: | 0.962 |
| Skin Sensitization: | 0.769 | Carcinogencity: | 0.62 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.013 |
| Respiratory Toxicity: | 0.985 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003245 | ![]() |
0.826 | D02DMQ | ![]() |
0.273 | ||
| ENC005215 | ![]() |
0.750 | D01TSI | ![]() |
0.268 | ||
| ENC002680 | ![]() |
0.718 | D0V3ZA | ![]() |
0.261 | ||
| ENC002151 | ![]() |
0.691 | D09NNH | ![]() |
0.261 | ||
| ENC002679 | ![]() |
0.667 | D0W7WC | ![]() |
0.255 | ||
| ENC002681 | ![]() |
0.656 | D0SP3D | ![]() |
0.254 | ||
| ENC002442 | ![]() |
0.643 | D00YLW | ![]() |
0.252 | ||
| ENC004465 | ![]() |
0.626 | D09ZIO | ![]() |
0.246 | ||
| ENC003586 | ![]() |
0.626 | D0BV3J | ![]() |
0.245 | ||
| ENC004447 | ![]() |
0.618 | D0K0KH | ![]() |
0.241 | ||